| # | Drug | Count |
|---|---|---|
| 0 | OSIMERTINIB | 5 |
| 1 | CARBOPLATIN | 2 |
| 2 | AFATINIB | 1 |
| 3 | ALDESLEUKIN | 1 |
| 4 | CETUXIMAB | 1 |
| 5 | CISPLATIN | 1 |
| 6 | ERDAFITINIB | 1 |
| 7 | ETOPOSIDE | 1 |
| 8 | GEFITINIB | 1 |
| 9 | MITOMYCIN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERDAFITINIB | 1 | 0.0008 |
| 1 | ALDESLEUKIN | 1 | 0.0008 |
| 2 | MITOMYCIN | 1 | 0.0003 |
| 3 | AFATINIB | 1 | 0.0002 |
| 4 | GEFITINIB | 1 | 0.0001 |
| 5 | CETUXIMAB | 1 | 0.0000 |
| 6 | PEMETREXED DISODIUM | 1 | 0.0000 |
| 7 | CARBOPLATIN | 2 | 0.0000 |
| 8 | ETOPOSIDE | 1 | 0.0000 |
| 9 | CISPLATIN | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 1 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 2 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Platinum-based Drug [EPC] | 3 | 0.0000 |
| 4 | Kinase Inhibitor [EPC] | 6 | 0.0000 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 6 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 1 | 0.0000 |